首页> 外文期刊>Hepato-gastroenterology. >Accompanying liver cirrhosis as a risk factor for recurrence after resection of solitary hepatocellular carcinoma.
【24h】

Accompanying liver cirrhosis as a risk factor for recurrence after resection of solitary hepatocellular carcinoma.

机译:伴发肝硬化是孤立性肝细胞癌切除术后复发的危险因素。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND/AIMS: A high recurrence rate after hepatic resection adversely influences the postoperative prognosis of patients with hepatocellular carcinoma. In the present study, long-term results and prognostic factors were evaluated in patients who underwent hepatic resection for solitary hepatocellular carcinoma. METHODOLOGY: The records of 105 patients who underwent hepatic resection for hepatocellular carcinoma between June 1978 and April 2000 were retrospectively reviewed. In 61 patients with solitary hepatocellular carcinoma who survived the curative operation, the prognostic significance of 11 clinicopathological parameters was investigated by univariate and multivariate analyses. RESULTS: After curative resection, the cumulative survival rate at 5 years in these 61 patients with solitary hepatocellular carcinoma was significantly better than in 25 patients with multiple hepatocellular carcinomas (44% vs. 25%, p = 0.01). However, even in the solitary group, the cumulative recurrence-free survival rate at 5 years was only 32%; and in 27 (75%) of 36 patients, in whom recurrence was confirmed within 5 years, hepatocellular carcinoma recurred within 2 years. Multivariate analysis disclosed that only accompanying liver cirrhosis was a variable having prognostic significance for overall and recurrence-free survival. A study of other clinicopathological factors, including tumor size, failed to demonstrate any prognostic value. CONCLUSIONS: The present result suggests that hepatic resection can be indicated in patients with solitary hepatocellular carcinoma, irrespective of its size. Though the postoperative recurrence associated with the underlying cirrhosis is still frequent, long-term survival can be expected if the recurrent tumors are successfully treated by a strategy using multiple modalities.
机译:背景/目的:肝切除术后高复发率对肝细胞癌患者的术后预后产生不利影响。在本研究中,对因单发性肝细胞癌进行肝切除的患者的长期结果和预后因素进行了评估。方法:回顾性分析了1978年6月至2000年4月间105例因肝细胞癌进行肝切除的患者的病历。通过单因素和多因素分析,对61例行手术治愈的孤立性肝细胞癌患者的临床预后意义进行了研究。结果:根治性切除后,这61例单发性肝细胞癌患者5年的累积生存率显着优于25例多发性肝细胞癌患者(44%vs. 25%,p = 0.01)。但是,即使是单独的组,其5年累积无复发生存率也仅为32%。在36例患者中,有27例(75%)在5年内被确认复发,而肝细胞癌则在2年内复发。多变量分析显示,只有伴随性肝硬化才是对总体生存和无复发生存具有预后意义的变量。对其他临床病理因素(包括肿瘤大小)的研究未能显示出任何预后价值。结论:目前的结果表明,无论大小,孤立性肝癌患者均可行肝切除术。尽管与潜在肝硬化相关的术后复发仍很频繁,但如果采用多种方式成功治疗复发性肿瘤,则有望长期生存。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号